Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:
Evolve Intellectual Property joins the ranking this year having continued to expand its client roster. Lead partner Stephen Gurney built up extensive in-house experience before forming the firm in 2022. He is a European, UK and Australian patent attorney, and he combines strong pharmaceutical and IP knowledge to assist with drug development and IP, portfolio management and prosecution, licensing, due diligence, and litigation. He recently assisted biopharmaceutical company Pharma Mar S.A. with the development of its UP strategy.
Legal 500 redaktioneller Kommentar
Kernmandanten
- Pharma Mar S.A.
- DRI Healthcare
Highlight-Mandate
Advised DRI Healthcare in relation to two Royalty Purchase Agreements for elacestrant worth $225 million.
- Advised OMERS Life Sciences in relation to the purchase of a Portion of Global Royalties for MAVYRET® worth $200 million.